Keyphrases
Cost-effectiveness
100%
Asthma
100%
Policy Model
100%
Inhaled Corticosteroids
100%
Quality-adjusted Life Years
100%
Mild-to-moderate Asthma
100%
Inhaled Corticosteroid Therapy
75%
Acute Exacerbation
50%
Life-years Gained
50%
Symptom-free Days
50%
Reliever
50%
United States
25%
Moderate to Severe
25%
Patient Preference
25%
Randomized Trial
25%
Patient Survey
25%
Health Care Costs
25%
Forced Expiratory Volume in 1 Second (FEV1)
25%
Clinical Impact
25%
State-based
25%
Health-related Quality of Life
25%
Health Impact
25%
Economic Cost
25%
Natural History of Disease
25%
Adult Asthma
25%
Drug Efficacy
25%
Cost-effectiveness Analysis
25%
Observational Cohort
25%
Evaluation Outcomes
25%
Limited Resources
25%
Incremental Cost
25%
Resource Condition
25%
Life Cost
25%
Health Costs
25%
Short-acting
25%
Comparative Values
25%
Planning Horizon
25%
Acute Hospitalization
25%
Mathematical Simulation Model
25%
Medicine and Dentistry
Health Care Cost
100%
Cost-Effectiveness Analysis
100%
Asthma
100%
Quality Adjusted Life Year
66%
Corticosteroid Therapy
50%
Side Effect
33%
Quality of Life
16%
Clinician
16%
Patient Preference
16%
Drug Efficacy
16%
Diseases
16%
Nursing and Health Professions
Cost Effectiveness Analysis
100%
Asthma
100%
Quality Adjusted Life Year
80%
Corticosteroid Therapy
60%
Side Effect
40%
Quality of Life
20%
Compliance
20%
Health Care Cost
20%
Patient Preference
20%
Drug Induced Disease
20%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Side Effect
50%
Drug Induced Disease
25%